In a 2015 study by Cheng et al., it was found that Longikaurin E promoted the apoptosis of PANC-1 human pancreatic cancer cells by reducing the Bcl-2/Bax ratio and activating Caspase-3 (Cheng et al., 2015). This evidence concerns the gene CASP3 and pancreatic neoplasm.